Nipocalimab

nipocalimab · Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Nipocalimab, covering 2025-03-04 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Nipocalimab in Moderate to Severe Sjogren's Disease [Phase 3]